Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.

Authors:
Shimizu K; Okita R; Saisho S; Yukawa T; Maeda A and 2 more

Journal:
Ann Nucl Med

Publication Year: 2015

DOI:
10.1007/s12149-015-1013-3

PMCID:
PMC4666280

PMID:
26254228

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Nucl Med

Abbreviation: Ann Nucl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
Singh SB; Bhandari S; Bhandari S and 7 more (2024) - Transparency Score: 3/6
Effect of scan-time shortening on the <sup>11</sup>C-PHNO binding potential to dopamine D<sub>3</su…
Matsunaga K; Tonomura M; Abe K and 1 more (2023) - Transparency Score: 3/6
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early s…
Makino A; Kume K; Mori T and 4 more (2023) - Transparency Score: 3/6
Practice recommendation for measuring washout rates in <sup>123</sup>I-BMIPP fatty acid images.
Nakajima K; Miyauchi H; Hirano KI and 4 more (2023) - Transparency Score: 3/6
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals.
Jeong YJ; Yoon HJ; Kang DY and 1 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors have no competing interests to declare."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025